Pharmaceutical Market Unattractive To MultinationalsAugust 2012 | Industry Trend Analysis
BMI View: Although Ecuador's pharmaceutical market is small in global terms, there is significant growth potential. The major disincentive for multinational drugmakers to launch their products in Ecuador is the limited size of the pharmaceutical market, the preference for affordable generic drugs, low prevalence of chronic diseases, and a weak business environment. However, foreign generic drugmakers can seek to increase their presence in the country's drug market as it relies heavily on imported medicines.
To read the full article, please choose one of the following options: